
Read More
Lupin Signs License and Supply Agreement with Spektus to Commercialise Nove...
This collaboration significantly strengthens Lupin’s Central Nervous System (CNS) portfolio, providi...

This collaboration significantly strengthens Lupin’s Central Nervous System (CNS) portfolio, providi...

Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics...

This partnership, facilitated through Lupin’s subsidiary Lupin Atlantis Holdings SA (LAHSA), targets...

The stock is up by 19.33 per cent from its 52-week low and has given multibagger returns of 185 per ...

Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return ...

The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing F...

The company has consistently maintained a robust dividend payout ratio of 18.2 per cent. ...

The company has delivered returns of 41.8 per cent over the past year....

A global pharmaceutical company, has announced the launch of Thiamine Hydrochloride Injection USP, f...

Watch out for these large-cap stocks in Thursday’s trading session!...